PHARMACYCLICS INC
10-Q, EX-27.1, 2000-11-13
PHARMACEUTICAL PREPARATIONS
Previous: PHARMACYCLICS INC, 10-Q, EX-10.1, 2000-11-13
Next: YOUNG INNOVATIONS INC, 10-Q, 2000-11-13



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
UNAUDITED CONDENSED BALANCE SHEET AND UNAUDITED CONDENSED STATEMENT OF
OPERATIONS AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL
STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          JUN-30-2001
<PERIOD-START>                             JUL-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                          33,022
<SECURITIES>                                    79,473
<RECEIVABLES>                                      116
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                               116,318
<PP&E>                                           8,833
<DEPRECIATION>                                   5,009
<TOTAL-ASSETS>                                 180,615
<CURRENT-LIABILITIES>                            6,208
<BONDS>                                              0
                                0
                                          0
<COMMON>                                             2
<OTHER-SE>                                     174,375
<TOTAL-LIABILITY-AND-EQUITY>                   180,615
<SALES>                                              0
<TOTAL-REVENUES>                                   110
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                11,273
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   1
<INCOME-PRETAX>                                 (8215)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (8,215)
<EPS-BASIC>                                     (0.51)
<EPS-DILUTED>                                   (0.51)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission